Status:
COMPLETED
Eyelid Closure in Glaucoma Therapy
Lead Sponsor:
Johns Hopkins University
Conditions:
Glaucoma
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This research is being done to determine if closing your eyelids after you take your glaucoma drops makes them more effective in lowering your eye pressure, and to determine if closing your eyelids fo...
Detailed Description
* Abstract * Eye drops to lower intraocular pressure (IOP) remain the principal therapy for glaucoma. The path from the writing of a prescription of IOP-lowering drops to optimal lowering of IOP an...
Eligibility Criteria
Inclusion
- Age over 18 years, use of one of the three topical prostaglandins (latanoprost, travaprost, or bimatoprost), and no other IOP-lowering eye drops for at least one month.
Exclusion
- Previous laser or incisional surgery for glaucoma, use of punctual plugs, an abnormal slit lamp exam (except for cataract or intraocular lens implant) and incisional eye surgery within the last 6 months.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00832832
Start Date
January 1 2009
End Date
January 1 2011
Last Update
September 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins - The Wilmer Eye Institute
Baltimore, Maryland, United States, 21009